Identifying novel cancer treatments drives us.
Acute Myeloid Leukemia
Hairy Cell Leukemia
Adult T-Cell Leukemia
Accelerating the discovery of novel, antibody-targeted leukemia therapies
We’re on a mission to accelerate the discovery of antibody-targeted drug therapies that increase survival and life quality of leukemia patients. An active partner in the open science ecosystem, Leukemia Therapeutics combines the best of academic medicine with the power of Pharma to accelerate discovery of novel therapies for leukemia.